$46 mill loss, page-3

The significant profits you speak of are not yet in the bag unfortunately. The last set of results were not good for the stock, and there remains a VERY REAL risk that the FDA will throw further hurdles in their way as a result of the tests not reaching statistical significance. That is why the stock cratered to $2.00 and is stuck there.

I don't want to sound blindly negative, but it is my genuine belief that PXS will face hurdles. FDA has thrown enough at them already and it is no fait accompli that they will get approval 'as is'.

There are more mountains to climb yet for PXS, unfortunately.